(HealthDay)—A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ultrasonography (US), according to research ...
A multicenter American College of Radiology Imaging Network trial has determined that breast lesions categorized as BI-RADS 3 or probably benign have low malignancy rates, suggesting that follow-up ...
OAK BROOK, Ill. - Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that ...
Receiving your mammogram results can be an emotional experience. Whether the news is positive or requires further investigation, it’s important to understand what these results mean for your breast ...
Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing The Breast Imaging Reporting and Data System (BI-RADS) lexicon ...
Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be ...
Leesburg, VA, July 15, 2021--According to ARRS' American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) ...
Breast cancer is the leading cause of cancer-related death among Brazilian women. Understanding the regional disparities in mammographic screening coverage is essential for improving early detection ...
Response-Guided Neoadjuvant Chemo Beneficial in Breast CA A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results